HD Wegovy (7.2mg), although delivering a competitive efficacy profile to Tirzepatide, it lacks the comparable tolerability profile and with a jump from 2.4mg to 7.2mg with no in between titration doses, I feel Novo missed a trick here
Adults with a BMI of at least 30, or at least 27 with weight-related health issues like high blood pressure or sleep apnea can join
It does not treat type 1 diabetes and is unsafe for some people with thyroid conditions
Fibrosis risk assessment In line with NICE guideline NG49, GPs may use the FIB-4 score to stratify risk: a score below 1.3 generally indicates low risk of advanced fibrosis, whilst a score above 2.67 (or above 2.0 in patients aged over 65) warrants further assessment, typically with enhanced liver fibrosis (ELF) testing or referral to hepatology
Breast Cancer Res
Complete symptom resolution, particularly for neurological complications, can take 318 months of regular treatment depending on deficiency severity